
Navacaprant—a novel, oral, once-daily, highly selective kappa opioid receptor antagonist that is currently in phase 3 development as a monotherapy for major depressive disorder.

Navacaprant—a novel, oral, once-daily, highly selective kappa opioid receptor antagonist that is currently in phase 3 development as a monotherapy for major depressive disorder.

From dopamine detoxification for problem gaming to connections between bacteria and anxiety and depression, here are highlights from the week in Psychiatric Times.

What is new in research on bipolar disorder?

What is the psychiatrist’s role in climate change? One reader responds.

How can we offer options and hope for the future to patients with treatment-resistant depression?


How can you learn from, appreciate, and grieve for other cultures?


2023 World AIDS Day looks to remember those who have been lost and a renewed commitment to supporting patients with HIV/AIDS.

The results suggest that the bacterium Lactobacillus may aid in the management of stress and in the prevention of these disorders.

The experts weighed in on a wide variety of psychiatric issues for the November 2023 issue of Psychiatric Times.

Here are some updates from the world of psychiatry throughout the month of November.

The FDA’s decision is set for September 2024.

Rosalynn Carter’s life can serve as an example to us all.
How does one heal? Perhaps by "degrees of revealedness," according to a psychiatrist's reflections.

Examine this case in which a patient presents with extreme constipation.

How do specific calendar days impact mental health?

Problematic gaming is often recognized in clinical practice, but can be challenging to treat. Here’s what you can do.

From late-life treatment-resistant depression to the mental health benefits of gratitude, here are highlights from the week in Psychiatric Times.

What is new in research on anxiety symptoms and disorders?

Tell us what you're thankful for!

Psychiatric Times revisits some meaningful reflections on Thanksgiving, family traditions, and the value of gratitude and thankfulness.

A psychiatrist reflects on gratitude and Thanksgiving...

In tough times, the cultivation of gratitude can help our patients—and us, too.

Exploring new opportunities to offset the unique obstacles seen in rural communities.

In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.

A psychiatrist reflects on how much we all have in common and the need for healing...

Ketamine for anxiety? Researchers performed a systematic review and meta-analysis of ketamine’s anxiolytic effects.

A poetic conversation among a Palestinian Israeli psychologist, an Italian Canadian psychiatrist, and a Canadian United Church Pastor in a time of war.
